|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
5/2008
vol. 7 abstract:
Local oestradiol administration – Vagifem®. Multicentre study
Janina Markowska
,
Jacek P. Grabowski
,
Anita Olejek
,
Iwona Kozak-Darmas
,
Włodzimierz Baranowski
,
Andrzej Polaszewski
,
Maciej Skrzypczak
,
Natalia Fischer
,
Radosław Mądry
,
Kornelia Tomaszewska
,
Ewa Muszyńska-Wiese
,
Anna Wawrzyniak
Przegląd Menopauzalny 2008; 5: 256-259
Online publish date: 2008/10/29
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
137 women who underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy or in some cases received radiotherapy due to cervical and endometrial cancer were observed for local Vagifem® (25 mg oestradiol) therapy evaluation. After 6 months of vaginal administration we noted a significant improvement of the symptoms: atrophic vaginitis, urinary incontinence, dysuric symptoms, bacterial infection as well as reported dyspareunia.
keywords:
oestradiol, atrophic vaginitis |
 |
